| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |